Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)

The summary for the Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed): The purpose of this notice of funding opportunity (NOFO) is to solicit applications to participate in a consortium of Research Centers focused on designing, optimizing, evaluating, and developing broadly protective vaccines for hepatitis C virus to enable the advancement of vaccine candidates into clinical evaluation.

Federal Grant Title:	Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AI-25-012
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.855
CFDA Descriptions:	Information not provided
Current Application Deadline:	November 7th, 2025
Original Application Deadline:	November 7th, 2025
Posted Date:	September 24th, 2025
Creation Date:	September 24th, 2025
Archive Date:	December 13th, 2025
Total Program Funding:
Maximum Federal Grant Award:	$2,000,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	September 24th, 2025

Applicants Eligible for this Grant: State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For-profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification.)
Additional Information on Eligibility: Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; U.S. Territory or Possession.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-AI-25-012.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Limited Competition: National Biocontainment Laboratories (NBLs) Operations Support (UC7 C...; • Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed); • Influenza Transmission Research Consortium (P01 Clinical Trial Optional); • Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed); • Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection a...; • Center for HIV/AIDS Vaccine Immunology (CHAVI); • Genomics of Transplantation Cooperative Research Program; • Asthma and Allergic Diseases Cooperative Research Centers
More Grants from the National Institutes of Health: • Mind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechan...; • Dynamic and Adaptable Infrastructure for Drug Development and Outreach to Aid the Research...; • NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial N...; • Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial N...; • Development of Novel or Improved Infertility Technologies (R61/R33 Clinical Trial Optional...